share_log
Breakings ·  Oct 1 04:05
Repare Therapeutics Announces Phase 1 Data Highlighting Camonsertib in Combination With Radiotherapy Treatment Presented at the Astro Annual Meeting
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment